Age (years) | |
 Mean ± SD | 69.0 ± 11.5 |
Gender (n) | |
 Female | 87 |
Race (n) | |
 Caucasian | 74 |
 Asian | 6 |
 Black | 1 |
 Other | 16 |
 Patient refused to answer | 3 |
Visit type (n) | |
 New patient visit | 38 |
 Established patient visit | 62 |
Interval between current and next visits, months (mean ± SD) | 4.43 ± 2.85 |
Patients with follow up within 6 months of current visit (n) | 44 |
Indications for initial treatment (n) | |
 T-score less than −2.5 | 49 |
 Fragility fracture | 17 |
 Osteopenia with positive FRAX® risk | 6 |
Patients managed on different prior therapies (n) | 54 |
 One prior therapy | 29 |
 Two prior therapies | 18 |
 Three prior therapies | 7 |
Total duration of any prior therapiesa (months) | |
 Mean ± SD | 73.4 ± 81.9 |
 Median (range) | 48 (0.25–458) |
Bone turnover marker(s) checked within 7 months of current visit (n) | 68 |